The impact of Cochrane Systematic Reviews: A mixed method evaluation of outputs from Cochrane Review Groups supported by the UK National Institute for Health Research

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Bunn, Frances ^a   Trivedi, Daksha ^a   Alderson, Phil ^b   Hamilton, Laura ^a   Martin, Alice ^a   Iliffe, Steve ^c  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Clinical guidance; Cochrane collaboration; Research impact; Systematic reviews

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TRANEXAMIC ACID;

ARTICLE; ASTHMA; BIBLIOMETRICS; CLINICAL PRACTICE; COCHRANE LIBRARY; COLLOID; COST EFFECTIVENESS ANALYSIS; CRYSTALLOID; DATA ANALYSIS; DECUBITUS; ECONOMICS; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH IMPACT ASSESSMENT; HEALTH SERVICE; INJURY; INTERVIEW; INTRARATER RELIABILITY; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTEMATIC REVIEW (TOPIC); FINANCIAL MANAGEMENT; LITERATURE; UNITED KINGDOM;

GREAT BRITAIN; HEALTH IMPACT ASSESSMENT; RESEARCH SUPPORT AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 84927943215     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-125     Document Type: Article

References (61)

1. Ham C, Hunter DJ, Robinson R. Evidence based policymaking. BMJ 1995, 310(6972):71-72. 10.1136/bmj.310.6972.71, 2548491, 7833721.
2. Dawes M, Summerskill W, Glasziou P, Cartabellotta A, Martin J, Hopayian K, Porzsolt F, Burls A, Osborne J. Sicily statement on evidence-based practice. BMC Med Educ 2005, 5(1):1. 10.1186/1472-6920-5-1, 544887, 15634359.
3. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996, 312(7023):71-72. 10.1136/bmj.312.7023.71, 2349778, 8555924.
4. Swan J, Clarke A, Nicolini D, Powell J, Scarborough H, Roginski C, Gkeredakis E, Mills P, Taylor-Phillips S. Evidence in Management Decisions (EMD)-Advancing Knowledge Utilization in Healthcare Management Final Report. NIHR Health Service and Delivery Research Programme 2012, [http://www.netscc.ac.uk/hsdr/files/project/SDO_FR_08-1808-244_V01.pdf].
5. HEFC Research Excellence Framework: Second Consultation on the Assessment and Funding of Research 2009, London: Higher Education Funding Council for England, HEFC.
6. Sheldon TA. Making evidence synthesis more useful for management and policy-making. J Health Serv Res Policy 2005, 10(Suppl 1):1-5.
7. Black N. Evidence based policy: proceed with care. BMJ 2001, 323(7307):275-279. 10.1136/bmj.323.7307.275, 1120888, 11485961.
8. Lomas J. Using 'linkage and exchange' to move research into policy at a Canadian foundation. Health Aff (Millwood) 2000, 19(3):236-240. 10.1377/hlthaff.19.3.236, 10812803.
9. Weiss C. Using research in the policy process: potential and constraints. Pol Stud J 1976, 4:224-228.
10. Olsen O, Middleton P, Ezzo J, Gotzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh H. Quality of Cochrane reviews: assessment of sample from 1998. BMJ 2001, 323(7317):829-832. 10.1136/bmj.323.7317.829, 57800, 11597965.
11. Moseley AM, Elkins MR, Herbert RD, Maher CG, Sherrington C. Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy. J Clin Epidemiol 2009, 62(10):1021-1030. 10.1016/j.jclinepi.2008.09.018, 19282144.
12. Jorgensen A, Hilden J, Gotzsche P. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006, 333(7572):782. 10.1136/bmj.38973.444699.0B, 1602036, 17028106.
13. Huberman M. Linking the practitioner and researcher communities for school improvement. Sch Eff Sch Improv 1993, 4:1-16.
14. Nutley S, Percy-Smith J, Solesbury W. Models of Research Impact: A Cross-Sector Review of Literature and Practice 2003, London: Learning and Skills Research Centre.
15. Estabrooks CE. The conceptual structure of research utilization. Res Nurs Health 1999, 22:203-216. 10.1002/(SICI)1098-240X(199906)22:3<203::AID-NUR3>3.0.CO;2-9, 10344701.
16. Buxton M, Hanney S. How can payback from health services research be assessed?. J Health Serv Res Policy 1996, 1(1):35-43.
17. Hanney S, Packwood T, Buxton M. Evaluating the benefits from health research and development centres: a categorization, a model and examples of application. Evaluation: Int J Theory Res Pract 2000, 6(2):137-160.
18. Kuruvilla S, Mays N, Pleasant A, Walt G. Describing the impact of health research: a Research Impact Framework. BMC Health Serv Res 2006, 6:134. 10.1186/1472-6963-6-134, 1635046, 17049092.
19. Kuruvilla S, Mays N, Walt G. Describing the impact of health services and policy research. J Health Serv Res Policy 2007, 12(Suppl 1):S1. -23-31.
20. Boaz A, Fitzpatrick S, Shaw B. Assessing the Impact of Research on Policy: A Review of the Literature for a Project on Bridging Research and Policy Through Outcome Evaluation 2008, London: University of London.
21. Hanney SR, Grant J, Wooding S, Buxton MJ. An assessment of the impact of NHS Health Technology Assessment Programme. Health Technol Assess 2007, 11(53):1-180.
22. Lavis J, Ross S, McLeod C, Gildiner A. Measuring the impact of health research. J Health Serv Res Policy 2003, 8(3):165-170. 10.1258/135581903322029520, 12869343.
23. Hanney S, Grant J, Wooding S, Buxton M. Proposed methods for reviewing the outcomes of health research: the impact of funding by the UK's 'Arthritis Research Campaign'. Health Res Pol Syst 2004, 2(1):4.
24. Coffey A, Atkinson P. Making Sense of Qualitative Data: Complementary Research Strategies 1996, New York: Sage.
25. Altmetric What does Altmetric do?. [http://www.altmetric.com/whatwedo.php#score], Altmetric.
26. Piwowar H. Altmetrics: what, why and where. Bull Assoc Inform Sci Technol 2013, 39(4):8-9. [https://asis.org/Bulletin/Apr-13/AprMay13_Piwowarhtml].
27. McInnes E, Bell-Syer SE, Dumville JC, Legood R, Cullum NA. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev 2008, 4:CD001735.
28. Burnett J, Clift M, Sprange K. Buyers Guide: Pressure-Redistribution Mattresses and Overlays CEP08042 2008, London: NHS Purchasing and Supply Agency, Centre for Evidence-Based Purchasing.
29. Cates CJ, Lasserson TJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2009, 1:CD007694.
30. Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2009, 3:CD006922.
31. Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2008, 3:CD006363. 4015854, 18646149.
32. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011, 3:CD000567.
33. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007, 4:CD000567.
34. European Medicines Agency: PRAC Recommends Suspending Marketing Authorisations for Infusion Solutions Containing Hydroxyethyl Starch. London: EMA; 2013 [http://www.ema.europa.eu/docs/en_GB/document_library/ Referrals_document/Solutions_for_infusion_containing_hydroxyethyl_starch/Recommendation_provided_by_Pharmacovigilance:Risk_Assessment_Committee/WC500144448.pdf]
35. Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2009, 4:CD001869.
36. Roberts I, Shakur H, Ker K, Coats T. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2011, 1:CD004896.
37. Roberts I, Shakur H, Ker K, Coats T. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2009, 12:CD004896.
38. Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009, 2:CD007146.
39. Cameron ID, Murray GR, Gillespie LD, Robertson MC, Hill KD, Cumming RG, Kerse N. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010, 1:CD005465.
40. Meho LI. The rise and rise of citation analysis. Phys World 2007, 20(1):32-36.
41. Bunn F. The impact of systematic reviews on health care policy in England 2010, PhD dissertation: University of Hertfordshire.
42. The Cochrane Library 2010 Impact Factor. Cochrane database of systematic reviews (CDSR). Frequently asked questions. [http://www.thecochranelibrary.com/SpringboardWebApp/userfiles/ccoch/file/Impact%20Factor/FAQ%20for%202010%20IF.pdf].
43. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 2008, 22(2):338-342.
44. Cozzens SE. The knowledge pool: measurement challenges in evaluating fundamental research programs. Eval Program Plann 1997, 20(1):77-89.
45. Comroe J, Dripps R. Scientific basis for the support of biomedical science. Biomedical Scientists and Public Policy 1978, 15-33. US: Springer, Hugh Fudenberg H, Melnick VL.
46. Becker L, Oxman AD. Chapter 22: overview of reviews. Cochrane Handbook for Systematic Reviews of Interventions Version 5.10 [updated March 2011] 2011, Oxford: The Cochrane Collaboration, Higgins J, Churchill R, Cumpston M, Chandler J, [http://www.cochrane-handbook.org].
47. Peckham S, Willmott M, Allen P, Anderson S, Goodwin N. Assessing the impact of the NHS Service Delivery and Organisation Research and Development Programme. Evid Pol: J Res Debate Pract 2008, 4:313-330.
48. Bunn F, Sworn K. Strategies to promote the impact of systematic reviews on healthcare policy: a systematic review of the literature. Evid Pol: J Res Debate Pract 2011, 7(4):403-428.
49. Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res 2014, 14:2. 10.1186/1472-6963-14-2, 3909454, 24383766.
50. Gillies D, Maxwell H, New K, Pennick V, van der Wouden H, Fedorowicz Z, Verbeek J, Ciapponi A. Collaboration-wide survey of Cochrane authors. 2009, [http://www.cochrane.org/collaboration-wide-survey-of-cochrane-authors].
51. Ismail S, Nason E, Marjanovic S, Grant J. Bibliometrics as a Tool for Supporting Prospective R&D Decision-Making in the Health Sciences: Strengths, Weaknesses and Options for Future Development 2009, RAND: Santa Monica.
52. van Leeuwen TN, Moed HF, Reedijk J. Critical comments on Institute for Scientific Information impact factors: a sample of inorganic molecular chemistry journals. J Inf Sci 1999, 25(6):489-498.
53. Sabatier PA. An advocacy coalition framework of policy change and the role of policy-oriented learning therein. Pol Sci 1988, 21(2-4):129-168.
54. Sheldon TA, Cullum N, Dawson D, Lankshear A, Lowson K, Watt I, West P, Wright D, Wright J. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ 2004, 329(7473):999. 10.1136/bmj.329.7473.999, 524545, 15514342.
55. Ryan J, Piercy J, James P. Assessment of NICE guidance on two surgical procedures. Lancet 2004, 363(9420):1525-1526. 10.1016/S0140-6736(04)16180-1, 15135602.
56. Thomas L, Cullum N, McColl E, Rousseau N, Soutter J, Steen N. Guidelines in professions allied to medicine. Cochrane Database Syst Rev 2000, 2:CD000349.
57. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993, 342(8883):1317-1322. 10.1016/0140-6736(93)92244-N, 7901634.
58. Grimshaw J, Freemantle N, Wallace S, Russell I, Hurwitz B, Watt I, Long A, Sheldon T. Developing and implementing clinical practice guidelines. Qual Health Care 1995, 4(1):55-64. 10.1136/qshc.4.1.55, 1055269, 10142039.
59. Martin HT, Mark JD, Jamie MF, Corey GR, Vivian HC, David JC, Peter BL. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ 2011, 342:d2392. 10.1136/bmj.d2392, 3086390, 21540258.
60. Grimshaw J, Thomas R, MacLennan G, Fraser C, Ramsay C, Vale L, Whitty P, Eccles M, Matowe L, Shirran L. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004, 8(6):1-72.
61. Gold M. Pathways to the use of health services research in policy. Health Serv Res 2009, 44(4):1111-1136. 10.1111/j.1475-6773.2009.00958.x, 2739019, 19490163.